Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer

By Pabalan Noel  

Breast Cancer Research and Treatment, Vol. 124, Iss. 2, 2010-11 ,pp. : 531-541

Springer Publishing Company

Access to resources Recommend Favorite

The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 227-231

Springer Publishing Company

Access to resources Recommend Favorite

Polymorphisms of GSTP1, ERCC2 and TS3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients

By                  

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 648-654

Spandidos Publications

Access to resources Recommend Favorite

Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer

By Guo Yi   Fu Pingfu   Zhu Honglan   Reed Eddie   Remick Scot C.   Petros William   Mueller Michael D.   Yu Jing Jie  

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 286-292

Spandidos Publications

Access to resources Recommend Favorite

Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma

By Chen Huayun   Shao Cuijie   Shi Hongliu   Mu Yonggao   Sai Ke   Chen Zhongping  

Journal of Neuro-Oncology, Vol. 82, Iss. 3, 2007-05 ,pp. : 257-262

Springer Publishing Company

Access to resources Recommend Favorite